Results 221 to 230 of about 2,034,935 (392)

Predictors of Response to Emergent Therapies in Pediatric Immune Thrombocytopenia [PDF]

Candelaria O’Farrell, Taylor M. Luckie, Susan E. Kirk, Jennifer M. Geris, Michael E. Scheurer, Amanda B. Grimes   +5 more
openalex   +1 more source

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial [PDF]

, 2020
Yafei Yu, Miaomiao Wang, Yu Hou, Ping Qin, Qingshu Zeng, Wenzheng Yu, Xinhong Guo, Jingxia Wang, Xiaomin Wang, Guoqiang Liu, Xiaoxia Chu, Lan‐Yan Yang, Ying Feng, Fang Zhou, Zhaogang Sun, Mei Zhang, Xin Wang, Zhencheng Wang, Xuehong Ran, Hongguo Zhao, Lei Wang, Haiyan Zhang, Kehong Bi, Daqi Li, Chenglu Yuan, Ruirong Xu, Yili Wang, Yuhong Zhou, Jun Peng, Xinguang Liu, Ming Hou   +30 more
openalex   +1 more source

The diagnostic performance of the basic versus the detailed telomere Flow FISH test in young patients with aplastic anaemia

British Journal of Haematology, EarlyView.
Summary Identifying telomere biology disorders (TBDs) in patients with aplastic anaemia (AA) is essential for guiding appropriate care. Telomere length (TL) measurement by flow cytometry with fluorescence in situ hybridization supports diagnosis, but the real‐world performance of the basic test (lymphocytes and granulocytes) versus the detailed test ...
Nicholas F. DeCleene, Duc T. Nguyen, Susan E. Kirk, Hannah L. Helber, Ghadir S. Sasa, Alison A. Bertuch   +5 more
wiley   +1 more source

An Umbrella Review of Meta-Analyses on the Efficacy and Safety of Eltrombopag in Immune Thrombocytopenia. [PDF]

Health Sci Rep
Dabir M, Mousavi MK, Manteghi S, Mansoori MA, Karpasand F, Zoghi F, Payandeh M.   +6 more
europepmc   +1 more source

Expression and Significance of Regulatory B Cells in Patients with Immune Thrombocytopenia

, 2022
Wei Qian, Xiaoxia Zhang
openalex   +2 more sources

Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes

British Journal of Haematology, EarlyView.
Summary Patients with immune thrombocytopenia (ITP) remain a challenge to diagnose, manage and predict bleeding risk. A comprehensive assessment of platelet function may aid clinical management. This study assessed platelet parameters to predict bleeding in ITP.
Sidra A. Ali, Sarah M. Hicks, Lucy A. Coupland, Simone A. Brysland, Vijay Bhoopalan, Yee Lin Thong, Amandeep Kaur, Robert K. Andrews, Elizabeth E. Gardiner, Philip Y.‐I. Choi   +9 more
wiley   +1 more source

Haemostasis alterations in immune thrombocytopenia and their clinical significance. [PDF]

Res Pract Thromb Haemost
Pincez T, Mathews N, Bonnefoy A.
europepmc   +1 more source

2025 update on clinical trials in immune thrombocytopenia [PDF]

Hanny Al‐Samkari
openalex   +1 more source

Risk factors for silent cerebral infarction in immune‐mediated thrombotic thrombocytopenic survivors

British Journal of Haematology, EarlyView.
Summary Immune‐mediated thrombotic thrombocytopenic purpura (iTTP) survivors are predisposed to silent cerebral infarctions (SCI) defined as radiological evidence of brain ischaemia without focal symptoms. This study examined risk factors associated with SCI burden in iTTP survivors during remission.
Binish Javed, Jia Yu, Jenna Brown, Jay Meade, Gloria F. Gerber, Michael B. Streiff, Peggy Kraus, Samuel Merrill, Allyson M. Pishko, Jennifer Yui, Rakhi P. Naik, Robert A. Brodsky, Doris D. Lin, Shruti Chaturvedi   +13 more
wiley   +1 more source

Causal relationship between immune cells and idiopathic thrombocytopenic purpura: A bidirectional Mendelian randomization study

Rheumatology &Autoimmunity, EarlyView.
Heyi Zhang, Luyao Song, Ying Mao, Zerui Liu, Zhexi He, Mengxia Liu, Jingfang Zhang, Rui Zhao, Jing Luo, Shengxiao Zhang   +9 more
wiley   +1 more source